Clinical Trial

Safety Shot Announces Partnership with Digital Growth Platform VENDO

As Masters in the E-Commerce Space VENDO is Anticipated to Significantly Help to Grow the Safety Shot Brand Online. JUPITER,…

5 months ago

Veeva Announces Fiscal 2025 Second Quarter Results

Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif.,…

5 months ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO,…

5 months ago

Breakthrough Technology Proves Rapid Relief of Depression With Non-Invasive Brain Stimulation

MINERAL WELLS, TX / ACCESSWIRE / August 28, 2024 / Depression, a debilitating disorder affecting millions worldwide, may soon be…

5 months ago

CORRECTING and REPLACING OMNY Health Launches Dynamic GLP-1 Network of 600,000+ Patients to Fuel Clinical Research on Its Use

New Studies on the Use of These Medications in Adult and Pediatric Populations are Supported by the Data NetworkATLANTA--(BUSINESS WIRE)--Please…

5 months ago

EydisBio Awarded $2.6 Million Grant to Advance TAK1 Inhibitor Program for Systemic Sclerosis

DURHAM, N.C., Aug. 28, 2024 /PRNewswire/ -- EydisBio, an early-stage pharmaceutical company leveraging a novel approach to treating various autoimmune…

5 months ago

Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis

Partnership seeks to identify rheumatoid arthritis biomarkers to improve understanding of disease risk, progression, and treatment responses MORRISVILLE, N.C. and…

5 months ago

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the…

5 months ago

Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial

Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. -…

5 months ago

Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a…

5 months ago